33% of Type 1 Diabetes Patients Insulin-Free With Stem Cells 33% of Type 1 Diabetes Patients Insulin-Free With Stem Cells
Engraftment of Vertex Pharmaceutical ' s VX-880 stem cell –derived islets has now been achieved in six patients, two of whom are insulin-independent at 1 year.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Diabetes & Endocrinology News Source Type: news
More News: Allergy | Allergy & Immunology | Diabetes | Diabetes Type 1 | Endocrinology | Insulin | Stem Cell Therapy | Stem Cells